IP Library Granted Patent US 11,147,914
Granted Patent B2
US 11,147,914 · App. 15/893,145 · Granted Oct 19, 2021

Infusion pump system and method

Inventor: Mark C. Estes (Malibu, CA)
Assignee: Bigfoot Biomedical, Inc.
A61M5/14244A61M5/14546A61M5/14566A61M5/158G06F19/00G16H10/60G16H20/17G16H40/63G16H40/67A61M5/1456A61M2005/14208A61M2005/14268A61M2005/1586A61M2205/3515A61M2205/3569A61M2205/3576G05B2219/31197
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,147,914
App. No.
15/893,145
Granted
Oct 19, 2021
Kind
B2
Abstract

Some embodiments of an infusion pump system may be configured to wirelessly communicate with other devices using near field communication (NFC). In particular embodiments, by incorporating near field communication capabilities into the infusion pump system, user communications with the infusion pump system can be enhanced and simplified.

Claims (34)

1. An insulin delivery system, comprising:

an insulin delivery device comprising a portable housing defining a space to receive insulin and a drive system to dispense insulin from the portable housing, the insulin delivery device comprising control circuitry and at least one wireless communication device connected to the control circuitry;

a near field communication (NFC) device adapted to store or transmit information related to the treatment of diabetes; and

a smartphone comprising a touchscreen user interface and an NFC circuit, the smartphone being adapted to wirelessly communicate with the insulin delivery device, the smartphone being configured to:

responsive to the smartphone being tapped or bumped adjacent to or against the NFC device, wirelessly receiving data regarding treatment of diabetes from the NFC device; and

responsive to receiving the data regarding treatment of diabetes from the NFC device, identifying a suggested bolus dosage of insulin, based, at least in part, on the information related to the treatment of diabetes and triggering a prompt on the touchscreen user interface for the user to confirm or deny the suggested bolus dosage of insulin.

2. The system of claim 1 , wherein the NFC device is an NFC tag that stores information regarding a number of carbohydrates to be consumed by a user.

3. The system of claim 2 , wherein the NFC tag stores a single carbohydrate value and does not store and cannot communicate a carbohydrate value other than the single carbohydrate value.

4. The system of claim 1 , wherein the prompt to the user on the touchscreen user interface prompts the user to enter a blood glucose level on the touchscreen user interface.

5. The system of claim 1 , wherein the touchscreen user interface includes a portion of the touchscreen user interface that is labeled “YES” and a portion that is labeled “NO.”

6. The system of claim 1 , wherein the smartphone further comprises an accelerometer adapted to detect movement of the smartphone to determine when the smartphone is bumped against the NFC device.

7. The system of claim 1 , wherein the touchscreen user interface of the smartphone is adapted to permit the user to change an amount value of the suggested bolus dosage prior to administration of the bolus dosage by the insulin delivery device.

8. The system of claim 1 , wherein the touchscreen user interface of the smartphone is adapted to permit the user to review data regarding past insulin deliveries.

9. The system of claim 1 , wherein the smartphone and the insulin delivery device communicate via BLUETOOTH®.

10. The system of claim 1 , wherein the insulin delivery device further comprises a second NFC circuit electrically connected with the control circuitry, wherein the second NFC circuit is configured to wirelessly receive infusion pump task data from the smartphone or the NFC device when the second NFC circuit and the smartphone or the NFC device are positioned within a NFC proximity range.

11. The system of claim 1 , wherein the smartphone comprises an accelerometer, wherein the smartphone is configured to detect acceleration movement of the smartphone and to communicate the detected movement to control circuitry of the smartphone or to the control circuitry of the insulin delivery device in order to compare a characteristic value of the detected movement to a threshold movement value.

12. The system of claim 1 , wherein the NFC device stores a single suggested bolus dosage value and does not store and cannot communicate a bolus dosage value other than the single suggested bolus dosage value.

13. A medical infusion pump system, comprising:

a portable pump comprising:

a housing defining a space to receive a medicine;

a pump drive system to dispense medicine from the housing when the medicine is received in the space;

control circuitry that communicates control signals to the pump drive system to control dispensation of the medicine from the housing when the medicine is received in the space;

a first near field communication (NFC) circuit electrically connected with the control circuitry to communicate infusion pump task data to the control circuitry, wherein the first NFC circuit is configured to wirelessly receive the infusion pump task data from a NFC communicator device when the first NFC circuit and NFC communicator device are positioned within a NFC proximity range; and

a wireless communication device different from the first NFC circuit connected to the control circuitry; and

a smartphone, the smartphone being configured to wirelessly communicate with the wireless communication device connected to the control circuitry, and the smartphone comprising a second NFC circuit, wherein the smartphone is configured to:

responsive to the smartphone being tapped or bumped adjacent to or against the NFC communicator device, wirelessly receiving infusion pump task data from the NFC communicator device; and

responsive to receiving the infusion pump task data from the NFC communicator device, identifying a suggested bolus dosage of insulin, based, at least in part, on the information related to the treatment of diabetes and triggering a prompt a user to deliver insulin according to the suggested bolus dosage of insulin.

14. The system of claim 13 , wherein the smartphone comprises an accelerometer, wherein the smartphone is configured to detect acceleration movement of the smartphone and to communicate the detected movement to control circuitry of the smartphone or to the control circuitry of the portable pump in order to compare a characteristic value of the detected movement to a threshold movement value.

15. The system of claim 13 , wherein the NFC communicator device is an NFC tag that stores information regarding a number of carbohydrates to be consumed by a user.

16. The system of claim 15 , wherein the NFC tag stores a single carbohydrate value and does not store and cannot communicate a carbohydrate value other than the single carbohydrate value.

17. The system of claim 13 , wherein the smartphone further comprises an accelerometer adapted to detect movement of the smartphone to determine when the smartphone is bumped against the NFC communicator device.

18. The system of claim 13 , wherein the NFC communicator device stores a single suggested bolus dosage value and does not store and cannot communicate a bolus dosage value other than the single suggested bolus dosage value.

19. The system of claim 13 , wherein the control circuitry of the portable pump is configured to cause the smartphone to provide a prompt to the user to confirm or deny delivering insulin according to another suggested bolus dosage of insulin in response to the first NFC circuit receiving the infusion pump task data from the NFC communicator device when the first NFC circuit and NFC communicator device are positioned within a NFC proximity range.

20. The system of claim 19 , wherein the user can confirm or deny delivering insulin according to another suggested bolus dosage of insulin by bringing the second NFC circuit within a threshold distance of the NFC communicator device.

Assignments (18)
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 062900/0001 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: ASANTE SOLUTIONS, INC.
To: ASANTE LLC
Reel/Frame 052290/0903 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: ASANTE LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 052290/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: ESTES, MARK C.
To: ASANTE SOLUTIONS, INC.
Reel/Frame 052286/0341 →
Cited By (10)
US 12,208,241 US 12,249,421 US 12,272,438 US 12,296,139 US 12,403,255 US 12,437,862 US 12,462,930 US 12,482,554 US 12,502,478 US 12,555,082